Athos Capital Limited
Overview
Athos Capital Limited is a Hong Kong-based hedge fund manager established in 2011 that focuses on event-driven strategies in the Asia-Pacific region.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Brii Biosciences | Jul 2021 | IPO | Co-investor |
| Rokit Health Ltd | Jul 2025 | Convertible Debt | Co-investor |
| Kyoto Drug Discovery & Development Co., Ltd. | May 2024 | Private Placement | Lead |
| esspride株式会社 | Dec 2024 | Private Placement | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Athos Capital Limited based?
Athos Capital Limited is headquartered in Hong Kong, Hong Kong.
When was Athos Capital Limited founded?
Athos Capital Limited was founded in 2011.
How many portfolio companies does Athos Capital Limited have?
Athos Capital Limited has 4 portfolio companies in Caplight's dataset.
What are some companies in Athos Capital Limited's portfolio?
Portfolio companies visible on Caplight include Brii Biosciences, Rokit Health Ltd, Kyoto Drug Discovery & Development Co., Ltd., esspride株式会社.
What was Athos Capital Limited's most recent investment shown here?
Athos Capital Limited's most recent investment in this portfolio sample was in Rokit Health Ltd in 2025.
What sectors does Athos Capital Limited focus on?
Athos Capital Limited focuses on Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Media, Entertainment & Gaming.
What company stages does Athos Capital Limited focus on?
Stage focus information for Athos Capital Limited is not publicly available.
What is Athos Capital Limited's AUM?
Athos Capital Limited's assets under management are estimated at over $324.3M.